CKD and Mental Health: Descriptive variables Under review

Coding system: SNOMED CT (UK Clinical Edition)
Coding system release: 42.2.0
Author: David O'Hagan
Codelist ID: user/davidohagan/ckd-and-mental-health-descriptive-variables
Version ID: 2ac73584
Number of codes included: 14

Versions

Description

These are the variables for measurements and values
They are specific and usually are part of a mechanistic pathway

Methodology

Context

Is this for a specific purpose or context, if so what, or could it be used more broadly?

Inclusion/exclusion criteria

Describe the inclusion and exclusion criteria used to define the codelist.

Borderline cases

List any codes which were considered borderline, and explain why they were included/excluded.

Sensitivity vs specificity

Is the aim of this codelist to be specific (e.g. hypertension via confirmed diagnosis codes), or sensitive (e.g. flu via potential symptom codes)?

Additional information

Any other relevant information about the codelist.

Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.

We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.

code	term
1011481000000105	Estimated glomerular filtration rate using creatinine Chronic Kidney Disease Epidemiology Collaboration equation per 1.73 square metres
1011491000000107	Estimated glomerular filtration rate using cystatin C Chronic Kidney Disease Epidemiology Collaboration equation per 1.73 square metres
1020291000000106	Glomerular filtration rate calculated by abbreviated Modification of Diet in Renal Disease Study Group calculation
1107411000000104	Estimated glomerular filtration rate by laboratory calculation
241374009	Chromium 51 ethylenediamine tetra-acetate clearance - glomerular filtration rate
262300005	With glomerular filtration rate
326991000000101	Radionuclide non-imaging glomerular filtration rate estimation study
71000237105	Substance concentration ratio of calculated tubular maximum reabsorption of phosphate per litre of glomerular filtration rate to creatinine in urine
737105002	Glomerular filtration rate calculation technique
80274001	Glomerular filtration rate
857971000000104	Estimated glomerular filtration rate using Chronic Kidney Disease Epidemiology Collaboration formula
963601000000106	Estimated glomerular filtration rate using cystatin C Chronic Kidney Disease Epidemiology Collaboration equation
963621000000102	Estimated glomerular filtration rate using creatinine Chronic Kidney Disease Epidemiology Collaboration equation
996231000000108	Glomerular filtration rate calculated by abbreviated Modification of Diet in Renal Disease Study Group calculation adjusted for African American origin

This page shows the search terms that were used to build the codelist. Concepts that match the search terms, but which were excluded, are in faint grey.

gfr

Included 14 out of 66 matching concepts.

Show matching concepts

Amivantamab (1162751008)
Antigen of epidermal growth factor receptor (570091010000109)
Cetuximab (409400001)
Chromium 51 ethylenediamine tetra-acetate clearance - glomerular filtration rate (241374009)
Crouzon syndrome with acanthosis nigricans (702361006)
Eosinophilic leukaemia genotype determination (789801000000102)
Epidermal growth factor receptor (86960007)
Epidermal growth factor receptor inhibitor (734625009)
Erlotinib (414123001)
Erlotinib hydrochloride (426686007)
Estimated glomerular filtration rate by laboratory calculation (1107411000000104)
Estimated glomerular filtration rate using Chronic Kidney Disease Epidemiology Collaboration formula (857971000000104)
Estimated glomerular filtration rate using creatinine Chronic Kidney Disease Epidemiology Collaboration equation (963621000000102)
Estimated glomerular filtration rate using creatinine Chronic Kidney Disease Epidemiology Collaboration equation per 1.73 square metres (1011481000000105)
Estimated glomerular filtration rate using cystatin C Chronic Kidney Disease Epidemiology Collaboration equation (963601000000106)
Estimated glomerular filtration rate using cystatin C Chronic Kidney Disease Epidemiology Collaboration equation per 1.73 square metres (1011491000000107)
Fibroblast growth factor receptor 2-related bent bone dysplasia (778008009)
Fibroblast growth factor receptor 3-related craniosynostosis (440350001)
Fibroblast growth factor receptor inhibitor (1162484009)
Futibatinib (1351548001)
Gefitinib (407100002)
Glomerular filtration rate (80274001)
Glomerular filtration rate calculated by abbreviated Modification of Diet in Renal Disease Study Group calculation (1020291000000106)
Glomerular filtration rate calculated by abbreviated Modification of Diet in Renal Disease Study Group calculation adjusted for African American origin (996231000000108)
Glomerular filtration rate calculation technique (737105002)
Human epidermal growth factor receptor 2 inhibitor (784175006)
Infigratinib (1162483003)
Lapatinib (425820005)
Lapatinib ditosylate (426238006)
Lapatinib ditosylate anhydrous (1269168000)
Lapatinib ditosylate monohydrate (725960003)
Lazertinib (933451401000036107)
Lazertinib mesilate monohydrate (579861000202108)
Lazertinib mesylate (1373927003)
Margetuximab (1144474002)
Mobocertinib (40609711000001106)
Mobocertinib succinate (40618011000001101)
Muenke syndrome (787407003)
Myeloid and lymphoid neoplasm with fibroblast growth factor receptor 1 abnormality (721301004)
Myeloid and/or lymphoid neoplasm associated with platelet derived growth factor receptor alpha rearrangement (738527001)
Myeloid neoplasm associated with beta-type platelet-derived growth factor receptor gene rearrangement (724642009)
Myeloid neoplasm with beta-type platelet-derived growth factor receptor gene rearrangement (450941004)
Myeloid-lymphoid neoplasm with FGFR1 rearrangement (450942006)
Myeloid-lymphoid neoplasm with PDGFRA rearrangement (450940003)
Myeloid-lymphoid neoplasm with PDGFRB rearrangement (1251587000)
Necitumumab (716015005)
Nimotuzumab (765360008)
Non-small cell lung cancer, negative for epidermal growth factor receptor expression (427038005)
Non-small cell lung cancer, positive for epidermal growth factor receptor expression (426964009)
Osimertinib (716032009)
Osimertinib mesilate (734660003)
Panitumumab (423259008)
Pertuzumab (704226002)
Primary non-small cell lung cancer negative for epidermal growth factor receptor expression (1259768005)
Primary non-small cell lung cancer, positive for epidermal growth factor receptor expression (1259776007)
Radionuclide non-imaging glomerular filtration rate estimation study (326991000000101)
Substance concentration ratio of calculated tubular maximum reabsorption of phosphate per litre of glomerular filtration rate to creatinine in urine (71000237105)
Substance with epidermal growth factor receptor inhibitor mechanism of action (409402009)
Substance with fibroblast growth factor receptor inhibitor mechanism of action (1162485005)
Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (784176007)
Technetium-99m-diethylenetriamine pentaacetic acid clearance - glomerular filtration rate (241373003)
Trastuzumab (387003001)
Trastuzumab deruxtecan (838469001)
Trastuzumab emtansine (702836004)
Vandetanib (418260004)
With glomerular filtration rate (262300005)